{"id":"fluroxene","rwe":[],"tags":[{"label":"fluroxene","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"General anesthesia","category":"indication"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"fluoromar","offLabel":[],"synonyms":["fluroxene","fluoromar","fluoroxene","trifluoroethyl vinyl ether"],"timeline":[],"approvals":[],"brandName":"Fluoromar","ecosystem":[{"indication":"General anesthesia","otherDrugs":[{"name":"acetylcysteine","slug":"acetylcysteine","company":"Apothecon"},{"name":"alfentanil","slug":"alfentanil","company":"Akorn"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"amobarbital","slug":"amobarbital","company":""}],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","drugClass":"fluroxene","explanation":"Imagine your brain as a busy city with many different neighborhoods. Fluoromar helps quiet down the neighborhoods that control consciousness and memory, making it easier for patients to relax and undergo surgery without feeling pain or remembering the experience.","oneSentence":"Fluoromar works by inducing unconsciousness and amnesia through its effects on the central nervous system.","technicalDetail":"Fluoromar is a volatile anesthetic agent that exerts its effects by modulating the activity of gamma-aminobutyric acid (GABA) receptors in the brain, leading to a decrease in neuronal excitability and a loss of consciousness."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3242","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FLUROXENE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:36:37.800554","biosimilars":[],"competitors":[],"genericName":"fluroxene","indications":{"approved":[{"name":"General anesthesia","source":"DrugCentral","snomedId":50697003,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"001397","UNII":"FO7JHA3G03","CHEBI":"CHEBI:134757","INN_ID":"1278","UMLSCUI":"C0016381","ChEMBL_ID":"CHEMBL141446","KEGG_DRUG":"D04237","PUBCHEM_CID":"9844","MESH_SUPPLEMENTAL_RECORD_UI":"C084587"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fluoromar, also known as Fluroxene, is a small molecule drug in the fluroxene class. It is used for general anesthesia, but its target and exact mechanism of action are unknown. The commercial status of Fluoromar is unclear, and it may be patented or off-patent. As a general anesthetic, Fluoromar is used to induce unconsciousness and amnesia in patients undergoing surgery. However, more information is needed to fully understand its safety profile and usage.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":false,"score":2}}